Order of the Vice-President of the Court of 2 February 2024.#Neuraxpharm Pharmaceuticals SL v European Commission.#Appeal – Interim relief – Medicinal product for human use – Marketing authorisation – Extension of the marketing protection period – No urgency.#Case C-607/23 P(R).